Skip to main content
SpringerLink
Log in
Book cover

Pediatric Nephrology pp 799–814Cite as

Membranous Nephropathy in the Pediatric Population

  • Reference work entry

Abstract

Membranous nephropathy is a disease that typically presents with nephrotic syndrome, and although more common in the adult population, has been described in children, and even in the newborn. The disease is defined by the presence of subepithelial immune deposits (between the glomerular basement membrane (GBM) and the podocyte) with subsequent expansion of the GBM resulting in a membrane-like (membranous) thickening of the glomerular capillary wall.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   369.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976–1979 and 1995–1997. Am J Kidney Dis 1997;30:621–631.

    Article  PubMed  CAS  Google Scholar 

  2. Chen A, Frank R, Vento S et al. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol 2007;8:11.

    Article  PubMed  Google Scholar 

  3. Habib R, Kleinknecht C, Gubler MC. Extramembranous glomerulonephritis in children: report of 50 cases. J Pediatr 1973;82:754–766.

    Article  PubMed  CAS  Google Scholar 

  4. Trainin EB, Boichis H, Spitzer A, Greifer I. Idiopathic membranous nephropathy. Clinical course in children. NY State J Med 1976;76:357–360.

    CAS  Google Scholar 

  5. Ramirez F, Brouhard BH, Travis LB, Ellis EN. Idiopathic membranous nephropathy in children. J Pediatr 1982;101:677–681.

    Article  PubMed  CAS  Google Scholar 

  6. Latham P, Poucell S, Koresaar A, Arbus G, Baumal R. Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study. J Pediatr 1982;101:682–685.

    Article  PubMed  CAS  Google Scholar 

  7. Tsukahara H, Takahashi Y, Yoshimoto M et al. Clinical course and outcome of idiopathic membranous nephropathy in Japanese children. Pediatr Nephrol 1993;7:387–391.

    Article  PubMed  CAS  Google Scholar 

  8. Obana M, Nakanishi K, Sako M et al. Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis. Clin J Am Soc Nephrol 2006;1:723–729.

    Article  PubMed  Google Scholar 

  9. Lee BH, Cho HY, Kang HG et al. Idiopathic membranous nephropathy in children. Pediatr Nephrol 2006;21:1707–1715.

    Article  PubMed  Google Scholar 

  10. Filler G, Young E, Geier P, Carpenter B, Drukker A, Feber J. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 2003;42:1107–1113.

    Article  PubMed  Google Scholar 

  11. Nangaku M, Shankland SJ, Couser WG. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 2005;16:1195–1204.

    Article  PubMed  CAS  Google Scholar 

  12. Cairns SA, London RA, Mallick NP. Circulating immune complexes in idiopathic glomerular disease. Kidney Int 1982;21:507–512.

    Article  PubMed  CAS  Google Scholar 

  13. Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 1978;62:1275–1287.

    Article  PubMed  CAS  Google Scholar 

  14. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL. Production of nephrotic syndrome in rats by Freund’s adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 1959;100:660–664.

    PubMed  CAS  Google Scholar 

  15. Farquhar MG, Saito A, Kerjaschki D, Orlando RA. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J Am Soc Nephrol 1995;6:35–47.

    PubMed  CAS  Google Scholar 

  16. Kerjaschki D, Noronha-Blob L, Sacktor B, Farquhar MG. Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border. J Cell Biol 1984;98:1505–1513.

    Article  PubMed  CAS  Google Scholar 

  17. Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983;157:667–686.

    Article  PubMed  CAS  Google Scholar 

  18. Kerjaschki D, Ullrich R, Diem K, Pietromonaco S, Orlando RA, Farquhar MG. Identification of a pathogenic epitope involved in initiation of Heymann nephritis. Proc Natl Acad Sci USA 1992;89:11179–11183.

    Article  PubMed  CAS  Google Scholar 

  19. Raychowdhury R, Zheng G, Brown D, McCluskey RT. Induction of Heymann nephritis with a gp330/megalin fusion protein. Am J Pathol 1996;148:1613–1623.

    PubMed  CAS  Google Scholar 

  20. Ronco P, Allegri L, Melcion C et al. A monoclonal antibody to brush border and passive Heymann nephritis. Clin Exp Immunol 1984;55:319–332.

    PubMed  CAS  Google Scholar 

  21. Ronco P, Allegri L, Brianti E, Chatelet F, Van Leer EH, Verroust P. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology. Appl Pathol 1989;7:85–98.

    PubMed  CAS  Google Scholar 

  22. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002;346:2053–2060.

    Article  PubMed  Google Scholar 

  23. Jefferson JA, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol 2003;23:400–405.

    Article  PubMed  Google Scholar 

  24. Falk RJ, Dalmasso AP, Kim Y et al. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 1983;72:560–573.

    Article  PubMed  CAS  Google Scholar 

  25. Kerjaschki D, Schulze M, Binder S et al. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 1989;143:546–552.

    PubMed  CAS  Google Scholar 

  26. Brenchley PE, Coupes B, Short CD, O’Donoghue DJ, Ballardie FW, Mallick NP. Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 1992;41:933–937.

    Article  PubMed  CAS  Google Scholar 

  27. Schulze M, Donadio JV, Jr., Pruchno CJ et al. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 1991;40:533–538.

    Article  PubMed  CAS  Google Scholar 

  28. Salant DJ, Belok S, Madaio MP, Couser WG. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 1980;66:1339–1350.

    Article  PubMed  CAS  Google Scholar 

  29. Baker PJ, Ochi RF, Schulze M, Johnson RJ, Campbell C, Couser WG. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol 1989;135:185–194.

    PubMed  CAS  Google Scholar 

  30. Brandt J, Pippin J, Schulze M et al. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 1996;49:335–343.

    Article  PubMed  CAS  Google Scholar 

  31. Spicer ST, Tran GT, Killingsworth MC et al. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats. J Immunol 2007;179:172–178.

    PubMed  CAS  Google Scholar 

  32. Perkinson DT, Baker PJ, Couser WG, Johnson RJ, Adler S. Membrane attack complex deposition in experimental glomerular injury. Am J Pathol 1985;120:121–128.

    PubMed  CAS  Google Scholar 

  33. Doi T, Mayumi M, Kanatsu K, Suehiro F, Hamashima Y. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 1984;58:57–62.

    PubMed  CAS  Google Scholar 

  34. Doi T, Kanatsu K, Nagai H, Suehiro F, Kuwahara T, Hamashima Y. Demonstration of C3d deposits in membranous nephropathy. Nephron 1984;37:232–235.

    Article  PubMed  CAS  Google Scholar 

  35. Moll S, Miot S, Sadallah S, Gudat F, Mihatsch MJ, Schifferli JA. No complement receptor 1 stumps on podocytes in human glomerulopathies. Kidney Int 2001;59:160–168.

    Article  PubMed  CAS  Google Scholar 

  36. Cai Y, Beziau A, Sich M, Kleppel MM, Gubler MC. Collagen distribution in human membranous glomerulonephritis. Pediatr Nephrol 1996;10:14–21.

    Article  PubMed  CAS  Google Scholar 

  37. Kim Y, Butkowski R, Burke B et al. Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol 1991;139:1381–1388.

    PubMed  CAS  Google Scholar 

  38. Torbohm I, Schonermark M, Wingen AM, Berger B, Rother K, Hansch GM. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int 1990;37:1098–1104.

    Article  PubMed  CAS  Google Scholar 

  39. Shankland SJ, Pippin J, Pichler RH et al. Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy. Kidney Int 1996;50:116–124.

    Article  PubMed  CAS  Google Scholar 

  40. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 1993;90:3645–3649.

    Article  PubMed  CAS  Google Scholar 

  41. Gwinner W, Plasger J, Brandes RP et al. Role of xanthine oxidase in passive Heymann nephritis in rats. J Am Soc Nephrol 1999;10:538–544.

    PubMed  CAS  Google Scholar 

  42. Shah SV. The role of reactive oxygen metabolites in glomerular disease. Annu Rev Physiol 1995;57:245–262.

    Article  PubMed  CAS  Google Scholar 

  43. Shah SV. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 1988;254:F337–F344.

    PubMed  CAS  Google Scholar 

  44. Andreoli SP, McAteer JA. Reactive oxygen molecule-mediated injury in endothelial and renal tubular epithelial cells in vitro. Kidney Int 1990;38:785–794.

    Article  PubMed  CAS  Google Scholar 

  45. Neale TJ, Ojha PP, Exner M et al. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 1994;94:1577–1584.

    Article  PubMed  CAS  Google Scholar 

  46. Watanabe K, Kinoshita S, Nakagawa H. Gelatinase secretion by glomerular epithelial cells. Nephron 1990;56:405–409.

    Article  PubMed  CAS  Google Scholar 

  47. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996;97:1094–1101.

    Article  PubMed  CAS  Google Scholar 

  48. Takano T, Cybulsky AV. Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells: role of cyclooxygenase-1 and -2. Am J Pathol 2000;156:2091–2101.

    Article  PubMed  CAS  Google Scholar 

  49. Lianos EA, Noble B. Glomerular leukotriene synthesis in Heymann nephritis. Kidney Int 1989;36:998–1002.

    Article  PubMed  CAS  Google Scholar 

  50. Cybulsky AV, Lieberthal W, Quigg RJ, Rennke HG, Salant DJ. A role for thromboxane in complement-mediated glomerular injury. Am J Pathol 1987;128:45–51.

    PubMed  CAS  Google Scholar 

  51. Stahl RA, Adler S, Baker PJ, Chen YP, Pritzl PM, Couser WG. Enhanced glomerular prostaglandin formation in experimental membranous nephropathy. Kidney Int 1987;31:1126–1131.

    Article  PubMed  CAS  Google Scholar 

  52. Kim YH, Goyal M, Kurnit D et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001;60:957–968.

    Article  PubMed  CAS  Google Scholar 

  53. Kriz W. Progression of chronic renal failure in focal segmental glomerulosclerosis: consequence of podocyte damage or of tubulointerstitial fibrosis? Pediatr Nephrol 2003;18:617–622.

    Article  PubMed  Google Scholar 

  54. Kanwar YS, Rosenzweig LJ. Altered glomerular permeability as a result of focal detachment of the visceral epithelium. Kidney Int 1982;21:565–574.

    Article  PubMed  CAS  Google Scholar 

  55. Schneeberger EE, O’Brien A, Grupe WE. Altered glomerular permeability in Munich-Wistar rats with autologous immune complex nephritis. Lab Invest 1979;40:227–235.

    PubMed  CAS  Google Scholar 

  56. Dandapani SV, Sugimoto H, Matthews BD et al. Alpha-actinin-4 is required for normal podocyte adhesion. J Biol Chem 2007;282:467–477.

    Article  PubMed  CAS  Google Scholar 

  57. Reiser J, Oh J, Shirato I et al. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem 2004;279:34827–34832.

    Article  PubMed  CAS  Google Scholar 

  58. Petermann AT, Krofft R, Blonski M et al. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int 2003;64:1222–1231.

    Article  PubMed  Google Scholar 

  59. Shankland SJ, Floege J, Thomas SE et al. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 1997;52:404–413.

    Article  PubMed  CAS  Google Scholar 

  60. Shankland SJ. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006;69:2131–2147.

    Article  PubMed  CAS  Google Scholar 

  61. Shankland SJ, Pippin JW, Couser WG. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney Int 1999;56:538–548.

    Article  PubMed  CAS  Google Scholar 

  62. Pippin JW, Durvasula R, Petermann A, Hiromura K, Couser WG, Shankland SJ. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest 2003;111:877–885.

    PubMed  CAS  Google Scholar 

  63. Nakatsue T, Koike H, Han GD et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int 2005;67:2239–2253.

    Article  PubMed  CAS  Google Scholar 

  64. Saran AM, Yuan H, Takeuchi E, McLaughlin M, Salant DJ. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. Kidney Int 2003;64:2072–2078.

    Article  PubMed  CAS  Google Scholar 

  65. Yuan H, Takeuchi E, Taylor GA, McLaughlin M, Brown D, Salant DJ. Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 2002;13:946–956.

    PubMed  CAS  Google Scholar 

  66. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17:2974–2984.

    Article  PubMed  CAS  Google Scholar 

  67. Camussi G, Rotunno M, Segoloni G, Brentjens JR, Andres GA. In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol 1982;128:1659–1663.

    PubMed  CAS  Google Scholar 

  68. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 1994;46:89–96.

    Article  PubMed  CAS  Google Scholar 

  69. Rangan GK, Pippin JW, Couser WG. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int 2004;66:1838–1848.

    Article  PubMed  CAS  Google Scholar 

  70. Lefaucheur C, Stengel B, Nochy D et al. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 2006;70:1510–1517.

    Article  PubMed  CAS  Google Scholar 

  71. Wakai S, Magil AB. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 1992;41:428–434.

    Article  PubMed  CAS  Google Scholar 

  72. Schulze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol 1993;142:179–187.

    PubMed  CAS  Google Scholar 

  73. Freedman BI, Spray BJ, Dunston GM, Heise ER. HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation. Am J Kidney Dis 1994;23:797–802.

    PubMed  CAS  Google Scholar 

  74. Scolari F, Amoroso A, Savoldi S et al. Familial membranous nephropathy. J Nephrol 1998;11:35–39.

    PubMed  CAS  Google Scholar 

  75. Short CD, Feehally J, Gokal R, Mallick NP. Familial membranous nephropathy. Br Med J (Clin Res Ed) 1984;289:1500.

    Article  CAS  Google Scholar 

  76. Bockenhauer D, Debiec H, Sebire N et al. Familial Membranous Nephropathy: An X-Linked Genetic Susceptibility? Nephron Clin Pract 2007;108:c10–c5.

    Article  PubMed  CAS  Google Scholar 

  77. Louis CU, Morgenstern BZ, Butani L. Thrombotic complications in childhood-onset idiopathic membranous nephropathy. Pediatr Nephrol 2003;18:1298–1300.

    Article  PubMed  Google Scholar 

  78. Hogan SL, Muller KE, Jennette JC, Falk RJ. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 1995;25:862–875.

    Article  PubMed  CAS  Google Scholar 

  79. Jha V, Ganguli A, Saha TK et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007;18:1899–1904.

    Article  PubMed  CAS  Google Scholar 

  80. Schieppati A, Mosconi L, Perna A et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993;329:85–89.

    Article  PubMed  CAS  Google Scholar 

  81. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003;23:324–332.

    Article  PubMed  Google Scholar 

  82. Shiiki H, Saito T, Nishitani Y et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 2004;65:1400–1407.

    Article  PubMed  Google Scholar 

  83. Troyanov S, Roasio L, Pandes M, Herzenberg AM, Cattran DC. Renal pathology in idiopathic membranous nephropathy: a new perspective. Kidney Int 2006;69:1641–1648.

    Article  PubMed  CAS  Google Scholar 

  84. Bazzi C, Petrini C, Rizza V et al. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis 2001;38:240–248.

    Article  PubMed  CAS  Google Scholar 

  85. Cameron JS. Membranous nephropathy in childhood and its treatment. Pediatr Nephrol 1990;4:193–198.

    Article  PubMed  CAS  Google Scholar 

  86. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861–869.

    Article  PubMed  CAS  Google Scholar 

  87. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456–1462.

    Article  PubMed  CAS  Google Scholar 

  88. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857–1863.

    Google Scholar 

  89. Stegeman CA, de Zeeuw D, de Jong PE. Treatment of idiopathic membranous nephropathy: the dilemma of who, when, and how. Nephrol Dial Transplant 1995;10:1982–1984.

    PubMed  CAS  Google Scholar 

  90. du Buf-Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis 2005;46:1012–1029.

    Article  PubMed  CAS  Google Scholar 

  91. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992;20:240–248.

    PubMed  CAS  Google Scholar 

  92. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 1979;301:1301–1306.

    Google Scholar 

  93. Branten AJ, du Buf-Vereijken PW, Vervloet M, Wetzels JF. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide. Am J Kidney Dis 2007;50:248–256.

    Article  PubMed  CAS  Google Scholar 

  94. Cameron JS, Healy MJ, Adu D. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Q J Med 1990;74:133–156.

    PubMed  CAS  Google Scholar 

  95. Cattran DC, Delmore T, Roscoe J et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989;320:210–215.

    Article  PubMed  CAS  Google Scholar 

  96. Cattran DC, Greenwood C, Ritchie S et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int 1995;47:1130–1135.

    Article  PubMed  CAS  Google Scholar 

  97. Ponticelli C, Altieri P, Scolari F et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998;9:444–450.

    PubMed  CAS  Google Scholar 

  98. Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995;48:1600–1604.

    Article  PubMed  CAS  Google Scholar 

  99. Praga M, Barrio V, Juarez GF, Luno J. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int 2007;71:924–930.

    Article  PubMed  CAS  Google Scholar 

  100. The Southwest Pediatric Nephrology Study Group. Comparison of idiopathic and systemic lupus erythematosus-associated membranous glomerulonephropathy in children. Am J Kidney Dis 1986;7:115–24.

    Google Scholar 

  101. Coupes BM, Kon SP, Brenchley PE, Short CD, Mallick NP. The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy. Nephrol Dial Transplant 1993;8:397–401.

    PubMed  CAS  Google Scholar 

  102. Debiec H, Nauta J, Coulet F et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 2004;364:1252–1259.

    Article  PubMed  CAS  Google Scholar 

  103. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990;37:663–676.

    Article  PubMed  CAS  Google Scholar 

  104. Takekoshi Y, Tochimaru H, Nagata Y, Itami N. Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy. Kidney Int Suppl 1991;35:S34–S39.

    PubMed  CAS  Google Scholar 

  105. Akano N, Yoshioka K, Aya N et al. Immunoelectron microscopic localization of membrane attack complex and hepatitis B e antigen in membranous nephropathy. Virchows Arch A Pathol Anat Histopathol 1989;414:325–330.

    Article  PubMed  CAS  Google Scholar 

  106. Hsu HC, Wu CY, Lin CY, Lin GJ, Chen CH, Huang FY. Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan. Kidney Int 1989;36:1103–1107.

    Article  PubMed  CAS  Google Scholar 

  107. Bhimma R, Coovadia HM, Ramjee G et al. Characterization of proteinuria in asymptomatic family members and household contacts of children with hepatitis B virus-associated membranous nephropathy. Am J Kidney Dis 2001;37:125–133.

    Article  PubMed  CAS  Google Scholar 

  108. Sithebe NP, Kramvis A, Kew MC, Bhimma R, Coovadia HM, Naidoo P. Hepatitis B and C virus co-infection in black children with membranous nephropathy. Pediatr Nephrol 2002;17:689–694.

    Article  PubMed  Google Scholar 

  109. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994;8:11–14.

    Article  PubMed  CAS  Google Scholar 

  110. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995;47:225–230.

    Article  PubMed  CAS  Google Scholar 

  111. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. HBV nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child 2003;88:446–449.

    Article  PubMed  CAS  Google Scholar 

  112. Filler G, Feber J, Weiler G, Le Saux N. Another case of HBV associated membranous glomerulonephritis resolving on lamivudine. Arch Dis Child 2003;88:460.

    Article  PubMed  CAS  Google Scholar 

  113. Butani L, Polinsky MS. Safety and efficacy of corticosteroids in childhood nephrotic syndrome with concomitant hepatitis B. Nephrol Dial Transplant 1999;14:1035–1036.

    Article  PubMed  CAS  Google Scholar 

  114. Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995;44:141–147.

    PubMed  CAS  Google Scholar 

  115. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991;59:319–320.

    Article  PubMed  CAS  Google Scholar 

  116. Davda R, Peterson J, Weiner R, Croker B, Lau JY. Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 1993;22:452–455.

    PubMed  CAS  Google Scholar 

  117. Chugh KS, Sakhuja V. Glomerular diseases in the tropics. Am J Nephrol 1990;10:437–450.

    Article  PubMed  CAS  Google Scholar 

  118. Nathanson S, Salomon R, Ranchin B et al. Prognosis of lupus membranous nephropathy in children. Pediatr Nephrol 2006;21:1113–1116.

    Article  PubMed  Google Scholar 

  119. Platt JL, Burke BA, Fish AJ, Kim Y, Michael AF. Systemic lupus erythematosus in the first two decades of life. Am J Kidney Dis 1982;2:212–222.

    PubMed  CAS  Google Scholar 

  120. Lau KK, Jones DP, Ault BH. Prognosis of lupus membranous nephritis in children. Lupus 2007;16:70.

    Article  PubMed  CAS  Google Scholar 

  121. Schwarz A, Krause PH, Offermann G, Keller F. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation. Transplantation 1994;58:650–654.

    PubMed  CAS  Google Scholar 

  122. Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y. Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol 1998;50:144–153.

    PubMed  CAS  Google Scholar 

  123. Poduval RD, Josephson MA, Javaid B. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol 2003;23:392–399.

    Article  PubMed  CAS  Google Scholar 

  124. Gomez-Campdera FJ, Niembro E. “De novo” membranous glomerulonephritis in renal allografts in children. Clin Nephrol 1989;31:279.

    PubMed  CAS  Google Scholar 

  125. Heidet L, Gagnadoux ME, Beziau A, Niaudet P, Broyer M, Habib R. Recurrence of de novo membranous glomerulonephritis on renal grafts. Clin Nephrol 1994;41:314–318.

    PubMed  CAS  Google Scholar 

  126. Hoitsma AJ, Kroon AA, Wetzels JF, Assmann KJ, Berden JH, Koene RA. Association between ureteral obstruction and de novo membranous nephropathy in renal allografts. Transplant Proc 1990;22:1388–1389.

    PubMed  CAS  Google Scholar 

  127. Zheng HL, Maruyama T, Matsuda S, Satomura K. Neuroblastoma presenting with the nephrotic syndrome. J Pediatr Surg 1979;14:414–419.

    Article  PubMed  CAS  Google Scholar 

  128. Locard-Bisot S, Cochat P, Gilly J et al. [Membranous glomerulonephritis in children: 20 cases]. Pediatrie 1990;45:527–532.

    PubMed  CAS  Google Scholar 

  129. Suzuki K, Tanaka H, Ito E, Waga S. Therapy-related membranous nephropathy in juvenile idiopathic arthritis with Turner syndrome. Pediatr Int 2004;46:377–379.

    Article  PubMed  Google Scholar 

  130. Ivanyi B, Haszon I, Endreffy E et al. Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen, and anti-tubular basement membrane nephritis: an 11-year follow-up. Am J Kidney Dis 1998;32:1068–1074.

    Article  PubMed  CAS  Google Scholar 

  131. Yoshioka K, Takemura T, Hattori S. Tubulointerstitial nephritis antigen: primary structure, expression and role in health and disease. Nephron 2002;90:1–7.

    Article  PubMed  CAS  Google Scholar 

  132. Tay AH, Ren EC, Murugasu B et al. Membranous nephropathy with anti-tubular basement membrane antibody may be X-linked. Pediatr Nephrol 2000;14:747–753.

    Article  PubMed  CAS  Google Scholar 

  133. Beck L, Bonegio R, Lambeau G, Powell T, Cummins D, Klein J, Salant D. Discovery of the phospholipase A2 receptor as the target antigen in idiopathic membranous nephropathy. J Am Soc Nephrol 2008;19:104A.

    Google Scholar 

Download references

Authors
  1. J. Ashley Jefferson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William G. Couser
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical College of Wisconsin, Wisconsin, USA

    Ellis Avner (Director, Children's Research Institute, CHHS, Associate Dean for Research, Professor of Pediatrics and Physiology) (Director, Children's Research Institute, CHHS, Associate Dean for Research, Professor of Pediatrics and Physiology)

  2. Harvard Medical School, Children's Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts, 02115, USA

    William Harmon (Professor of Pediatrics, Director, Pediatric Nephrology) (Professor of Pediatrics, Director, Pediatric Nephrology)

  3. Service de Néphrologie Pédiatrique Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Hôpital Necker‐Enfants Malades, 149, rue de Sèvres, 75743, Paris Cedex 15, France

    Patrick Niaudet

  4. Department of Pediatrics Wakayama Medical University, Wakayama Medical University Hospital, 641–8510811–1, Kimiidera, Wakayama City, Japan

    Norishige Yoshikawa (Professor and Chair Pediatrician‐in‐Chief) (Professor and Chair Pediatrician‐in‐Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Jefferson, J.A., Couser, W.G. (2009). Membranous Nephropathy in the Pediatric Population. In: Avner, E., Harmon, W., Niaudet, P., Yoshikawa, N. (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76341-3_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-76341-3_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-76327-7

  • Online ISBN: 978-3-540-76341-3

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation